GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Birc5 | affects expression | ISO | BIRC5 (Homo sapiens) | 6480464 | CTD | Daunorubicin affects the expression of BIRC5 mRNA | PMID:16638212 | Birc5 | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | CTD | Daunorubicin results in increased expression of BIRC5 mRNA; Daunorubicin results in increased expression of BIRC5 protein | PMID:16638212 PMID:27780733 | Birc5 | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | CTD | [bromotetrandrine co-treated with Daunorubicin] results in decreased expression of BIRC5 mRNA; [bromotetrandrine co-treated with Daunorubicin] results in decreased expression of BIRC5 protein; [Daunorubicin co-treated with bromotetrandrine co-treated with Magnetite Nanoparticles] results in decreased expression of BIRC5 mRNA; [Daunorubicin co-treated with bromotetrandrine co-treated with Magnetite Nanoparticles] results in decreased expression of BIRC5 protein; [Daunorubicin co-treated with bromotetrandrine] results in decreased expression of BIRC5 mRNA; [Daunorubicin co-treated with bromotetrandrine] results in decreased expression of BIRC5 protein | PMID:21362215 PMID:21720514 | | ||||||||||||||||||||||
| Go Back to source page | Continue to Ontology report |